Livero Inc.
9245.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥1 | ¥1 | ¥1 | ¥1 |
| % Growth | -19.7% | -1.8% | 64.3% | – |
| Cost of Goods Sold | ¥0 | ¥0 | ¥0 | ¥0 |
| Gross Profit | ¥1 | ¥1 | ¥1 | ¥1 |
| % Margin | 68.6% | 71.3% | 76.6% | 74.6% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥1 | ¥1 | ¥1 | ¥1 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | -¥0 |
| Operating Expenses | ¥1 | ¥1 | ¥1 | ¥1 |
| Operating Income | ¥0 | ¥0 | ¥0 | -¥0 |
| % Margin | 14.9% | 22.1% | 22.6% | -15.3% |
| Other Income/Exp. Net | ¥0 | ¥0 | ¥0 | ¥0 |
| Pre-Tax Income | ¥0 | ¥0 | ¥0 | -¥0 |
| Tax Expense | ¥0 | ¥0 | ¥0 | -¥0 |
| Net Income | ¥0 | ¥0 | ¥0 | -¥0 |
| % Margin | 10.3% | 14.7% | 14.8% | -7% |
| EPS | 19.3 | 34.3 | 34.98 | -10.11 |
| % Growth | -43.7% | -1.9% | 446% | – |
| EPS Diluted | 17.52 | 30.82 | 31.61 | -10.11 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥0 | ¥0 | ¥0 | -¥0 |
| % Margin | 17.3% | 23.6% | 24.2% | -13.5% |